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Abstract
Backgrounds and aim In recent decades, fibrin glue has
appeared as an alternative treatment for high perianal
fistulas. Early results seemed promising, with high success
rates being reported. However, with increasing follow-up,
the enthusiasm was tempered because of disappointing
results. The aim of this retrospective study was to assess the
additional value of fibrin glue in combination with
transanal advancement flap, compared to advancement flap
alone, for the treatment of high transsphincteric fistulas of
cryptoglandular origin.
Materials and methods Between January 1995 and January
2006, 127 patients were operated for high perianal fistulas
with an advancement flap. After exclusion of patients with
inflammatory bowel disease or HIV, 80 patients remained.
A consecutive series of 26 patients had an advancement
flap combined with obliteration of the fistula tract with
fibrin glue. Patients were matched for prior fistula surgery,
and the advancement was performed identically in all
patients. In the fibrin glue group, glue was installed
retrogradely in the fistula tract after the advancement was
completed and the fistula tract had been curetted.
Results Minimal follow-up after surgery was 13 months
[median of 67 months (range, 13–127)]. The overall
recurrence rate was 26% (n = 21). Recurrence rates for
advancement flap alone vs the combination with glue were
13% vs 56% (p = 0.014) in the group without previous
fistula surgery and 23% vs 41% (p = 0.216) in the group
with previous fistula surgery.
Conclusion Obliterating the fistula tract with fibrin glue
was associated with worse outcome after rectal advance-
ment flap for high perianal fistulas.
Keywords Rectalfistula.Surgery.Recurrence.
Fibringlue.Advancement
Introduction
Perianal fistulas of cryptoglandular origin cause consider-
able discomfort and arise from infections in anal glands
lying in the intersphincteric space [1]. To delineate the
fistula tract, magnetic resonance imaging (MRI) and anal
endosonography are nowadays readily available and are
increasingly used for fistula imaging [2]. The essence of
surgical treatment of perianal fistulas is to eradicate the
fistula tract and at the same time preserve continence. Low
fistulas, where the fistula tract is submucosal, intersphinc-
teric or located in the lower third of the external anal
sphincter can be treated by fistulotomy with low recurrence
rates and relatively little impact on continence [3]. In
patients with high perianal fistulas, the fistula tract is
located in the upper two-thirds of the external sphincter.
Fistulotomy performed on high fistulas results in loss of
sphincter function in a considerable number of patients due
to the interference of the external sphincter complex [4, 5].
There are various alternative surgical options for high
fistulas, namely, rectal advancement, fibrin glue, and seton
drainage.
In 2006, Johnson et al. [6] reported a new biologic anal
fistula plug to treat high transsphincteric perianal fistulas.
The anal fistula plug is biologic absorbable and consists of
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46 patients treated with the anal fistula plug, a success rate
of 83% was achieved at a median follow-up of 12 months
[7]. After this publication, several authors have reported
their experience with the anal fistula plug, resulting in
success rates ranging from 41–88% [8–10].
Currently, the transanal rectal advancement flap (AF)
remains the “gold standard” in the treatment of high
transsphincteric perianal fistulas of cryptoglandular origin.
The rationale behind the AF is that the open internal
opening is the cause of the persisting fistula tract. By
advancing the tissue over the internal opening, it would be
impossible for fecal material to be forced into the fistula
tract during defecation. However, recurrence rates of the
advancement flap found in literature vary considerably and
extend up to 63% [11–15]. Roughly, one out of every four
patients requires multiple surgical interventions to close the
fistula tract successfully.
In recent decades, fibrin glue has appeared as an
alternative treatment for high perianal fistulas. As a result
of the obliteration of the fistula tract and the closure of the
internal opening, the fistula might heal. Early results
seemed promising, with high success rates being reported.
However, with increasing follow-up, the enthusiasm was
tempered because of disappointing results [16–20]. Recent-
ly, Zmora et al. [21] conducted a retrospective study
including 37 patients with high perianal fistulas. In a subset
of 13 patients with fistulas of various etiologies, the
advancement flap was used in addition to the fibrin glue
installation. The results showed a recurrence rate of 46%.
The aim of this study was to assess the additional value
of fibrin glue to the transanal rectal advancement flap in a
well-defined group of patients with high transsphincteric
fistulas of cryptoglandular origin. Patients with previous
fistula surgery are a surgically more challenging group as
the result of scar tissue and sometimes anal stenosis.
Therefore, patients were matched for the presence of a
history of fistula surgery.
Materials and methods
Patient characteristics Between January 1995 and January
2006, a consecutive series of patients were treated by AF.
Only patients with high transsphincteric perianal fistulas of
cryptoglandular origin were analyzed. High perianal fistulas
were defined as patients with fistulas running through the
upper two thirds of the external sphincter complex, which is
confined by the puborectal sling and the end of the anal
canal. Patients in whom the internal fistula opening was not
detectable and patients with perianal fistulas as a result of
Crohn’s disease, HIV, and other causes were excluded.
Patients over 18years of age were included. A consecutive
series of patients were operated on with fibrin glue
(Tissucol Duo®, Baxter International) in addition to the
AF in an attempt to decrease the recurrence rate of the AF.
This series of patients were treated on between February
2003 and January 2006. Patients were matched for previous
surgery and divided into two groups; one group with
previous fistula surgery and the other without. Preopera-
tively, no routine imaging was performed. Only in selected
case when the fistula was complex and/or recurrent, MRI or
anal endosonography was used to outline the fistula tract. In
The Netherlands and Belgium, non-experimental clinical
case series of patients treated with a CE-approved device do
not require approval of the local Medical Ethics Commis-
sion. A subset of patients from this series were also
included in a study where the aim was to assess the long-
term functional outcome and identify risk factors for the
development of recurrence in patients surgically treated for
cryptoglandular fistulas [22].
Surgical technique On the day of surgery, an enema was
administered to the patient to clean the proctum. All
procedures were performed under general or locoregional
anesthesia in the lithotomy position, and broad spectrum
antibiotics were administered perioperatively. Subsequently,
the internal opening was located by probing the external
opening. During surgery, the amount of sphincter involved
was judged by palpation of the puborectal sling and the
inferior edge of the external sphincter complex. In cases
where the internal opening was not found by probing,
hydrogen peroxide was injected to locate the internal
opening. In case of active sepsis, a seton was placed for a
period of at least 3 months insuring adequate drainage. In
the group that was operated with the AF, the internal
opening was excised followed by mobilization of the
mucosa, submucosa, and a small amount of muscular fibers
from the internal sphincter complex. The rectal flap was
mobilized to sufficiently cover the internal opening with
overlap. Hemostasis was performed to prevent a hematoma
under the flap. The base of the advancement flap was kept
wide enough to ensure adequate circulation in the flap. The
internal opening was not closed before advancing the flap
over the internal opening. This was followed by suturing
the flap in the distal anal canal with Vicryl 2/0 after the
fistula tract had been curetted. In the AF + G group, the
identical procedure was carried out. In addition to the ad-
vancement procedure, fibrin glue was installed retrogradely
in the fistula tract after the AF was completed and the
fistula tract had been curetted. Installation of the fibrin glue
was performed via the external opening, under direct vision
of the advancement flap to prevent flap dislocation and
subsequent failure. No specific postoperative instructions
were given to the patients.
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gender, tertiary referral, previous fistula surgery, smoking
habits, complications, and fistula recurrence. All patients
visited the outpatient’s clinics on a regular basis (every 2–4
weeks) until full closure of the fistula tract was achieved.
The fistula was considered closed if the external opening
was closed and no discharge or pain was experienced;
otherwise, it was considered as a persistent or recurrent
fistula. No routine postoperative imaging or proctoscopy
was performed to confirm the closure of the fistula tract.
The data was collected retrospectively and the outcome was
compared between groups.
Statistical analysis Data are presented as median values
with ranges, unless otherwise specified. Categorical data
are presented as frequencies or percentages. Differences
between groups were tested using Mann–Whitney U test for
continuous data. Chi-square test or Fisher’s exact test were
used when appropriate to compare groups in case of
categorical or dichotomous variables. All reported p values
are two-sided. A p value of 5% or less was considered as
statistical significant. Statistical analysis was done using the
SPSS v.12.0 package (SPSS, Chicago, IL, USA).
Results
In the study period, a total of 127 patients were operated for
high perianal fistulas. Inflammatory bowel disease (n = 30),
HIV (n = 12), or no internal opening found during surgery
(n = 5) were the reason of exclusion in 47 patients. In total,
80 patients were analyzed in this comparative study. Of
these, 54 patients were treated with the AF and 26 patients
underwent AF combined with the installation of fibrin glue.
Furthermore, patients were matched for a history of fistula
surgery. Patient characteristics for both groups are shown in
Tables 1 and 2. The groups were comparable for patients’
characteristics as sex, age, smoking, seton drainage, and
number of tertiary referrals.
Clinical outcome All patients were operated in day case
setting. There were no intraoperative complications. In two
patients out of the AF group, a postoperative complication
was encountered, consisting of a minor bleeding (n = 1) and
a bradycardia for which the patient was observed overnight
(n = 1, patient with cardial history). In the AF + G group,
there were no postoperative complications recorded. The
minimal follow-up after surgery was 13 months with a
median of 67 months (range, 13–127). There were no
patients lost to follow-up. The overall recurrence rate was
26% (n = 21; Table 3.). In 17% of the patients, the fistula
persisted in the AF group compared to 46% in the AF + G
group (p = 0.05). In the matched group without previous
fistula surgery, the result was significantly worse for the
AF + G group compare to the AF group (p = 0.014). The
recurrence rates were 56% (n = 5) and 13% (n = 4),
respectively. In the group with a history of fistula surgery,
the recurrence rate was 23% (n = 5) compared to 41%
(n = 7) in the AF and the AF + G group, respectively
(p =0 . 2 1 6 ) .
Discussion
High perianal fistulas remain a surgical challenge. There are
various treatment options for treating high transsphincteric
fistulas, e.g., the rectal and anodermal advancement flap,
loose and cutting seton, fibrin glue, and potentially the
newly developed anal fistula plug [3]. However, the results
from these therapies vary. Transanal rectal advancement
Table 1 Characteristics of patients with high anorectal fistula without
previous fistula surgery
Variable AF (n=32)
a AF+G (n=9)
b p value
M/F (n) 18:14 6:3 0.711
Age (median, in years) 42 (21–67) 41 (29–55) 0.653
Tertiary referral 26 (81%) 7 (78%) 1.000
Smoking 43% 71% 0.232
Seton drainage 18 (56%) 6 (67%) 0.711
aRectal advancement group
bRectal advancement group with fibrin glue
Table 2 Characteristics of patients with high anorectal fistulas with
previous fistula surgery
Variable AF (n=22)
a AF+G (n=17)
b p value
M/F (n) 18:4 11:6 0.282
Age (median, in years) 43 (22–62) 47 (35–72) 0.136
Tertiary referral 15 (68%) 8 (47%) 0.209
Smoking 53% 50% 1.000
Seton drainage 10 (46%) 12 (71%) 0.193
aRectal advancement group
bRectal advancement group with fibrin glue
Table 3 Recurrence rates for the matched group analysis
Group AF
a AF+G
b p value
Overall (n=80) 9/54 (17%) 12/26 (46%) 0.050
No previous fistula surgery
(n=41)
4/32 (13%) 5/9 (56%) 0.014
Previous fistula surgery (n=39) 5/22 (23%) 7/17 (41%) 0.216
aRectal advancement group
bRectal advancement group with fibrin glue
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sphincter-saving approach. Due to the low recurrence rate
of only 30%, which leaves a lot of room for improvement
[11, 14], fibrin glue has been widely studied. Fibrin glue
was developed to obliterate the fistula tract by stimulating
fibroblasts, which leads to permanent closure of the fistula
tract. Unfortunately, the long-term results were not as good
as expected [19, 20]. In the present series, an attempt was
made to decrease the recurrence rate of the surgical
treatment of high transsphincteric perianal fistulas of
cryptoglandular origin by combining the two methods,
i.e., fibrin glue and the rectal advancement flap in a
consecutive series of patients. Overall, although not
significant, a clear trend was found consisting of a worse
outcome for patients from the AF + G group. The
recurrence rate was 46% compared to 17% in the AF + G
and AF group, respectively. In the group without a history
of fistula surgery, patients in the AF + G group did
significantly worse than the AF group. In the group with a
history of fistula surgery, no significantly different recur-
rence rates were found.
In 2003, Zmora et al. [21] described a small retrospec-
tive series of 13 patients with perianal fistulas of different
origins treated with fibrin glue in combination with the AF
[14]. In their series, a recurrence rate of 46% was found
after a mean follow-up of 12.1 months. The group
contained patients with fistulas of cryptoglandular origin
and fistulas associated with Crohn’s disease or surgical
trauma. In addition, two patients with rectovaginal fistulas
were included. More recently, Ellis and Clark [23] reported
on a series of 58 patients randomized into advancement flap
repair alone or advancement flap repair combined with
fibrin glue. Selected were patients with perianal fistulas
where the fistula tract comprised more than 30 to 50% of
the sphincter complex. Furthermore, patients were included
when the fistula was located anteriorly in women or when
the patient had a history of incontinence. In two thirds of the
patients, the mucosal advancement flap was used and the
remaining patients were treated by anodermal advancement
flap. The recurrence rate was significantly higher in the group
where fibrin glue was combined with the advancement flap
compared to the group treated only by advancement (46% vs
20%). Two techniques, i.e., mucosal advancement flap and
anodermal advancement flap, were used. Furthermore, no
information was provided on the distribution of causes of the
fistulas in both groups making the results difficult to interpret.
The effectiveness of the AF is the result of the closure of
the internal opening [24]. The reason why addition of fibrin
glue fails to decrease the recurrence rate and even seems to
worsen the result is still unclear. After AF, the fistula tract
acts as a drainage canal for any remaining sepsis, with the
external opening left open. With the installation of the fibrin
glue, a temporary closure of the fistula tract is theoretically
achieved. After a few weeks, when the clot resolves, the
fibroblasts activated by the matrix should provide collagen
syntheses for a definitive closure of the tract [25]. A possible
explanation to why the AF + G group does worse is that the
closure of the fistula tract with the fibrin glue leads to a
situation where insufficient drainage from the primary and
eventual secondary fistula tracts occurs.
Sentovich reported on a prospective series of 48 patients
(75% of cryptoglandular origin) treated with fibrin glue
[20]. In their technique of using the fibrin glue, the
procedure was combined with closure of the internal
opening with only a figure eight suture without an
advancement flap. After a median follow-up of 22 months,
a recurrence rate of 31% was found. Surprisingly, the
patients with longer fistula tracts did significantly worse
than those with short fistula tracts. Loungnarath et al. [26]
reported on 39 patients with perianal fistulas treated with
fibrin glue. The overall recurrence rate was 69%. In 6 of the
39 patients, the internal opening was closed using a figure
eight suture to avoid clot extrusion because of high pressure
from the anal canal during defecation. Four of these
patients had a recurrence (33%).
This retrospective study, in contrast to earlier studies [21,
23], assessed the additional value of fibrin glue to the
transanal rectal advancement flap of only patients with high
transsphincteric fistulas of cryptoglandular origin with a
long follow-up. The rectal advancement flap combined with
fibrin glue installation was associated with a significantly
higher recurrence rate, compared to the advancement flap
treatment alone, in patients without previous fistula surgery.
This observation must be interpreted carefully because of
the small sample size of the AF + G group. As the costs of
the fibrin glue are considerable and the therapeutic effect
very doubtful, it cannot be recommended routinely in the
adjunct of transanal rectal advancement flap treating high
perianal fistulas. The rectal advancement flap remains the
treatment of choice for high transsphincteric perianal
fistulas of cryptoglandular origin until novel methods like
the anal fistula plug are studied sufficiently in randomized
trials.
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